Transporter-mediated release: A superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 870-878

  Scholze, Petra ^a   Zwach, Julia ^a   Kattinger, Alexandra ^a   Pifl, Christian ^a   Singer, Ernst A ^a   Sitte, Harald H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; MONENSIN; OUABAIN; PAROXETINE; SEROTONIN TRANSPORTER;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIFFUSION; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; KIDNEY CELL; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONIN UPTAKE;

1-METHYL-4-PHENYLPYRIDINIUM; CARRIER PROTEINS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FENFLURAMINE; HUMANS; KIDNEY; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MONENSIN; MONOAMINE OXIDASE INHIBITORS; NERVE TISSUE PROTEINS; P-CHLOROAMPHETAMINE; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TRANSFECTION;

EID: 0034119972     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barker EL, Kimmel HL and Blakely RD (1994) Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol Pharmacal 46:799-807.
2. Blakely RD, Ramamoorthy S, Qian Y, Schroeter S and Bradley CC (1997) Regulation of antidepressant-sensitive serotonin transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith MEA ed) pp 29-73, Humana Press Inc, Totowa, NJ.
3. Bönisch H (1986) The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines. Naunyn-Schmiedeberg's Arch Pharmacol 332:135-141.
4. Chen N, Trowbridge CG and Justice J (1998) Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter. J Neurochem 71:653-665.
5. Cinquanta M, Ratovitski T, Crespi D, Gobbi M, Mennini T and Simantov R (1997) Carrier-mediated serotonin release induced by d-fenfluramine: Studies with human neuroblastoma cells transfected with a rat serotonin transporter. Neuropharmacology 36:803-809.
6. Collard KJ, Cassidy DM, Pye MA and Taylor RM (1981) The stimulus-induced release of unmetabolized 5-hydroxytryptamine from superfused rat brain synaptosomes. J Neurosci Methods 4:163-179.
7. Fuller RW, Hines CW and Mills J (1965) Lowering of rat brain serotonin levels by chloroamphetamines. Biochem Pharmacol 14:483-488.
8. 3H]serotonin. Naunyn-Schmiedeberg's Arch Pharmacol 345:1-6.
9. 3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur J Pharmacol 238:9-17.
10. Hilton SE, Maradit H and Moller HJ (1997) Serotonin syndrome and drug combinations: Focus on MAOI and RIMA. Eur Arch Psychiatry Clin Neurosci 247:113-119.
11. 3H]Substrate-and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux. Synapse 30:97-106.
12. Keyes SR and Rudnick G (1982) Coupling of transmembrane proton gradients to platelet serotonin transport. J Biol Chem 257:1172-1176.
13. Levi G and Raiteri M (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci 16:415-419.
14. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. Biochem Pharmacol 31:983-992.
15. Mollenhauer HH, Morre DJ and Rowe LD (1990) Alteration of intracellular traffic by monensin: Mechanism, specificity and relationship to toxicity. Biochim Biophys Acta 1031:225-246.
16. Pifl C, Agneter E, Drobny H, Sitte HH and Singer EA (1999) Amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: Superfusion studies on transfected cells. Neuropharmacology 38: 157-165.
17. Pifl C, Drobny H, Reither H, Hornykiewicz O and Singer EA (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: Plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47: 368-373.
18. Pifl C, Hornykiewicz O, Giros B and Caron MG (1996) Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: Studies comparing the cloned human noradrenaline and human dopamine transporter. J Pharmacol Exp Ther 277:1437-1443.
19. Prasad PD, Hoffmans BJ, Moe AJ, Smith CH, Leibach FH and Ganapathy V (1996) Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta 17:201-207.
20. Raiteri M, Angelini F and Levi G (1974) A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 25:411-414.
21. Raiteri M, Bonanno G, Marchi M and Maura G (1984) Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther 231:671-677.
22. Raiteri M, Cemto F, Cervoni AM, Del CR, Ribera MT and Levi G (1978) Release of dopamine from striatal synaptosomes. Ann 1st Super Sanita 14:97-110.
23. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang FT, Chang AS, Ganapathy V and Blakely RD (1993) Antidepressant-and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
24. Rudnick G (1997) Mechanism of biogenic amine neurotransmitter transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith MEA ed) pp 73-100, Humana Press Inc, Totowa, NJ.
25. Rudnick G, Kirk KL, Fishkes H and Schuldiner S (1989) Zwitterionic and anionic forms of a serotonin analog as transport substrates. J Biol Chem 264:14865-14868.
26. Rudnick G and Wall SC (1992) p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31:6710-6718.
27. Wall SC, Gu H and Rudnick G (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: Amphetamine specificity for inhibition and efflux. Mol Pharmacol 47:544-550.
28. + at low [alanine] and potential dependence for the system. J Membr Biol 165:275-282.